NEW YORK (GenomeWeb News) - The University of Ottawa Heart Institute is using Affymetrix technology for whole-genome association studies of coronary artery disease, the company said today.

 

The institute will use Affy’s Genome-Wide Human SNP Array 6.0 over the next three years to screen the DNA of more than 12,000 people to identify associations that could help in the development of personalized treatments for CAD.